- Home
- AUTL vs THFF Comparison
AUTL vs THFF Comparison
Compare AUTL & THFF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AUTL | THFF |
|---|---|---|
| Founded | 2014 | 1984 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 596.2M | 930.9M |
| IPO Year | 2025 | 1995 |
Fundamental Metrics
Financial Performance| Metric | AUTL | THFF |
|---|---|---|
| Price | $1.86 | $74.94 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 2 |
| Target Price | $8.50 | ★ $62.00 |
| AVG Volume (30 Days) | ★ 1.5M | 92.6K |
| Earning Date | 05-14-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 3.46% |
| EPS Growth | N/A | ★ 67.00 |
| EPS | N/A | ★ 3.58 |
| Revenue | ★ $10,120,000.00 | N/A |
| Revenue This Year | $80.32 | $17.88 |
| Revenue Next Year | $53.96 | $4.03 |
| P/E Ratio | ★ N/A | $21.14 |
| Revenue Growth | ★ 496.00 | N/A |
| 52 Week Low | $1.18 | $51.21 |
| 52 Week High | $2.58 | $84.17 |
Technical Indicators
Market Signals| Indicator | AUTL | THFF |
|---|---|---|
| Relative Strength Index (RSI) | 40.68 | 36.31 |
| Support Level | $1.84 | $74.32 |
| Resistance Level | $1.92 | $75.61 |
| Average True Range (ATR) | 0.09 | 1.59 |
| MACD | -0.02 | -0.22 |
| Stochastic Oscillator | 24.19 | 18.01 |
Price Performance
Historical ComparisonAbout AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8. Company's T cell programming technologies tailors therapies to address the specific disease targeting and introduce new programming modules into a patient's T cells to give those T cells improved properties to recognize target cells and overcome fundamental disease defense mechanisms.
About THFF First Financial Corporation Indiana
First Financial Corp operates as a financial holding company, which is engaged in the provision of financial services in the United States. The company offers a wide variety of financial services including commercial, mortgage, and consumer lending, lease financing, trust account services, depositor services and insurance services, through its subsidiaries. Its primary source of revenue is derived from loans to customers and investment activities. Company's loan portfolio was diversified in Commercial, Residential and consumer domains.